Host Toxicity: Since glycolysis is essential for host cells, inhibitors must be specific to pathogen enzymes to avoid toxicity. Pathogen Diversity: Different pathogens may rely on glycolysis to varying extents, requiring tailored approaches. Resistance Development: Pathogens can develop resistance to metabolic inhibitors, necessitating combination therapies.
